Abstract
In neuroblastic tumors a relationship of differentiation of the tumor to galanin receptor expression and antip roliferative and apoptotic effects upon activation of galanin receptors in neuroblastoma cells was reported. To elucidate the expression of other components of the galanin peptide family in neuroblastic tumors, RT-PCR analysis of a variety of human neuroblastic tumor tissues was performed. Ganglioneuroma tissues revealed the presence of a splice variant of the galanin-like peptide (GALP) mRNA, which results in exclusion of exon 3 and a frame shift after the signal peptide sequence of GALP. This generates a peptide of 25 amino acids, which we have termed alarin because of the N-terminal alanine and the C-terminal serine. The novel neuropeptide alarin does not reveal significant homology to other peptides. Immunohistochemistry with antibodies directed against synthetic alarin peptide detected specific cytoplasmic granular staining in ganglia of human ganglioneuroma and ganglioneuroblastoma, as well as differentiated tumor cells of neuroblastoma tissues. Undifferentiated neuroblasts of these tumor tissues did not show alarin-like immunoreactivity and alarin-specific mRNA. Our findings indicate that alarin expression is a feature of ganglionic differentiation in neuroblastic tumor tissues.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Berger A., Lang R., Moritz K., Santic R., Hermann A., Sperl W., and Kofler B. (2004) Galanin receptor subtype GalR2 mediates apoptosis in SH-SY5Y neuroblastoma cells. Endocrinology 145, 500–507.
Berger A., Santic R., Hauser-Kronberger C., Schilling F. H., Kogner P., Ratschek M. et al. (2005) Galanin and galanin receptors in human cancers. Neuropeptides 39, 353–359.
Berger A., Tuechler C., Almer D., Kogner P., Ratschek M., Kerbl R., et al. (2002) Elevated expression of galanin receptors in childhood neuroblastic tumors. Neuroendocrinology 75, 130–138.
Brodeur G. M., Seeger R. C., Barrett A., Berthold F., Castleberry R. P., D'Angio G. et al. (1988) International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J. Clin. Oncol. 6, 1874–1881.
Cunningham M. J., Shahab M., Grove K. L., Scarlett J. M., Plant T. M., Cameron J. L. et al. (2004) Galanin-like peptide as a possible link between metabolism and reproduction in the macaque. J. Clin. Endocrinol. Metab. 89, 1760–1766.
Enigk R. E. and Maimone M. M. (1999) Differential expression and developmental regulation of a novel alphadystrobrevin isoform in muscle. Gene 238, 479–488.
Gundlach A. L., Burazin T. C., and Larm J. A. (2001) Distribution, regulation and role of hypothalamic galanin systems: renewed interest in a pleiotropic peptide family. Clin. Exp. Pharmacol. Physiol. 28, 100–105.
Gustafson W. C., De Berry B. B., Evers B. M., and Chung D. H. (2005) Role of gastrointestinal hormones in neuroblastoma. World J. Surg. 29, 281–286.
Harmar A. J., Hyde V., and Chapman K. (1990) Identification and cDNA sequence of delta-preprotachykinin, a fourth splicing variant of the rat substance P precursor. FEBS Lett. 275, 22–24.
Helke C. J., Krause J. E., Mantyh P. W., Couture R., and Bannon M. J. (1990) Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms. FASEB J. 4, 1606–1615.
Hsiao C.C., Huang C.C., Sheen J.M., Tai M.H., Chen C.M., Huang L.L., and Chuang J.H. (2005) Differential expression of delta-like gene and protein in neuroblastoma, gang lioneuroblastoma and ganglioneuroma. Mod. Pathol. 18, 656–662.
Kerr N. C., Holmes F. E., and Wynick D. (2000) Galanin-like peptide (GALP) is expressed in rat hypothalamus and pituitary, but not in DRG. Neuroreport 11, 3909–3913.
Kogner P. (1995) Neuropeptides in neuroblastomas and ganglioneuromas. Prog. Brain Res 104, 325–338.
Kohchi C. and Tsutsui K. (2000) Avian galanin: cloning of complementary DNAs and characterization of transcripts in different tissues. J. Exp. Zool. 287, 183–190.
Lang R., Berger A., Santic R., Geisberger R., Hermann A., Herzog H., and Kofler B. (2005) Pharmacological and functional characterization of galanin-like peptide fragments as potent galanin receptor agonists. Neuropeptides 39, 179–184.
Larm J. A. and Gundlach A. L. (2000) Galanin-like peptide (GALP) mRNA expression is restricted to arcuate nucleus of hypothalamus in adult male rat brain. Neuroendocrinology 72, 67–71.
Ohtaki T., Kumano S., Ishibashi Y., Ogi K., Matsui H., Harada M., et al. (1999) Isolation and cDNA cloning of anovel galanin-like peptide (GALP) from porcine hypothalamus. J. Biol. Chem. 274, 37,041–37,045.
Perel Y., Amrein L., Dobremez E., Rivel J., Daniel J. Y., and Landry M. (2002) Galanin and galanin receptore expression in neuroblastic tumors: correlation with their differentiation status. Br. J. Cancer 86, 117–122.
Reubi J. C. (2003) Reptide receptors as molecular targets for cancer diagnosis and therapy. Endocr. Rev. 24, 389–427.
Rosenfeld M. G., Mermod J. J., Amara S. G., Swanson L. W., Sawchenko P. E., Rivier J., et al.(1983) Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304, 129–135.
Shen J., Larm J. A., and Gundlach A. L. (2001) Galanin-like peptide mRNA in neural lobe of rat pituitary. Increased expression after osmotic stimulation suggests a role for galanin-like peptide in neuron-glial interactions and/or neurosecretion. Neuroendocrinology 73, 2–11.
Shimada H., Ambros I. M., Dehner L. P., Hata J., Joshi V. V., and Roald B. (1999) Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 86, 349–363.
Sirand-Pugnet P., Durosay P., Clouet d'Orval B. C., Brody E., and Marie J. (1995) β-Tropomyosin pre-mRNA folding a round a muscle-specific exon interferes with several steps of spliceosome assembly. J. Mol. Biol. 251, 591–602.
Takatsu Y., Matsumoto H., Ohtaki T., Kumano S., Kitada C., Onda H., et al. (2001) Distribution of galanin-like peptide in the rat brain. Endocrinology 142, 1626–1634.
Unniappan S., Lin X., and Peter R. E. (2003) Characterization of complementary deoxyribonucleic acids encoding preprogalanin and its alternative splice variants in the goldfish. Mol. Cell. Endocrinol. 200, 177–187.
Wang Z., Marincola F. M., Rivoltini L., Parmiani G., and Ferrone S. (1999) Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells. Exp Med. 190, 205–215.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Santic, R., Fenninger, K., Graf, K. et al. Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide gene. J Mol Neurosci 29, 145–152 (2006). https://doi.org/10.1385/JMN:29:2:145
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:29:2:145